In adipocytes, c-Jun regulates HMGB1 secretion which bears strong correlation with non-alcoholic fatty liver disease (NAFLD) onset, primarily driven by the downstream effectors of insulin receptor [162,163,164]. Here, JUN is linked to metabolic dysfunction-associated steatotic liver disease.